Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies von VAN NES, S. I, VANHOUTTE, E. K, VAN DOORN, P. A, HERMANS, M, BAKKERS, M, KUITWAARD, K, FABER, C. G, MERKIES, I. S. J

Volltext

Early recognition of poor prognosis in Guillain-Barré syndrome von WALGAARD, C, LINGSMA, H. F, RUTS, L, VAN DOORN, P. A, STEYERBERG, E. W, JACOBS, B. C

Volltext

The Dutch neuromuscular database CRAMP (Computer Registry of All Myopathies and Polyneuropathies): Development and preliminary data von van Engelen, B.G.M, van Veenendaal, H, van Doorn, P.A, Faber, C.G, van der Hoeven, J.H, Janssen, N.G, Notermans, N.C, van Schaik, I.N, Visser, L.H, Verschuuren, J.J.G.M

Volltext

CMAP scan discontinuities: Automated detection and relation to motor unit loss von Sleutjes, B.T.H.M, Montfoort, I, Maathuis, E.M, Drenthen, J, van Doorn, P.A, Visser, G.H, Blok, J.H

Volltext

The Rasch-built Pompe-specific Activity (R-PAct) scale von van der Beek, N.A.M.E, Hagemans, M.L.C, van der Ploeg, A.T, van Doorn, P.A, Merkies, I.S.J

Volltext

Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease von Van der Beek, N.A.M.E, Hagemans, M.L.C, Reuser, A.J.J, Hop, W.C.J, Van der Ploeg, A.T, Van Doorn, P.A, Wokke, J.H.J

Volltext

Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease von van Capelle, C.I, Winkel, L.P.F, Hagemans, M.L.C, Shapira, S.K, Arts, W.F.M, van Doorn, P.A, Hop, W.C.J, Reuser, A.J.J, van der Ploeg, A.T

Volltext

Diagnostic and Classification Criteria for the Guillain-Barré Syndrome von van der Meché, F.G.A., van Doorn, P.A., Meulstee, J., Jennekens, F.G.I.

Volltext

Mild forms of Guillain-Barré syndrome in an epidemiologic survey in the Netherlands von VAN KONINGSVELD, R, VAN DOORN, P. A, SCHMITZ, P. I. M, ANG, C. W, VAN DER MECHE, F. G. A

Volltext

Cardiac evaluation in children and adults with Pompe disease sharing the common c.−32-13T>G genotype rarely reveals abnormalities von van der Beek, N.A.M.E, Soliman, O.I.I, van Capelle, C.I, Geleijnse, M.L, Vletter, W.B, Kroos, M.A, Reuser, A.J.J, Frohn-Mulder, I.M.E, van Doorn, P.A, van der Ploeg, A.T

Volltext

G.P.129 von Wens, S.C, Ciet, P, Perez-Rovira, A, Logie, K, Salamon, E, Wielopolski, P, Bruijne, M, Kruijshaar, M.E, Tiddens, H.W, van der Beek, N.A.M, van Doorn, P.A, van der Ploeg, A.T

Volltext

T.P.19 von de Vries, J.M, Kuperus, E, Hoogeveen-Westerveld, M, Wens, S.C.A, Kroos, M.A, Kruijshaar, M.E, van Doorn, P.A, van der Ploeg, A.T, Pijnappel, W.W.M

Volltext

P.17.1 Phenotypic variation within 22 families with Pompe disease von Wens, S.C.A, Van Gelder, C.M, Kruijshaar, M.E, De Vries, J.M, Van der Beek, N.A.M, Reuser, A.J.J, Van Doorn, P.A, Van der Ploeg, A.T, Brusse, E

Volltext

Distinguishing acute-onset CIDP from fluctuating Guillain-Barré syndrome: A prospective study von RUTS, L, DRENTHEN, J, JACOBS, B. C, VAN DOOM, P. A

Volltext

Prognostic factors of Guillain-Barré syndrome after intravenous immunoglobulin or plasma exchange von VISSER, L. H, SCHMITZ, P. I. M, MEULSTEE, J, VAN DOORN, P. A, VAN DER MECHE, F. G. A

Volltext

Impact of late-onset Pompe disease on participation in daily life activities: Evaluation of the Rotterdam Handicap Scale von Hagemans, M.L.C, Laforêt, P, Hop, W.J.C, Merkies, I.S.J, Van Doorn, P.A, Reuser, A.J.J, Van der Ploeg, A.T

Volltext

P4.40 Enzyme Replacement Therapy and prognostic factors for response: An ongoing open-label cohort study in adults with Pompe Disease von de Vries, J.M, van der Beek, N.A.M, Hagemans, M.L.C, Hop, W.C.J, Reuser, A.J.J, van Doorn, P.A, van der Ploeg, A.T

Volltext

P4.39 Enzyme replacement therapy during pregnancy and lactation in Pompe disease von de Vries, J.M, Brugma, J.C, Ozkan, L, Kroos, M.A, Steegers, E.A.P, Reuser, A.J.J, van Doorn, P.A, van der Ploeg, A.T

Volltext

P2.47 Anoctamin 5 mutations in the Dutch limb girdle muscular dystrophy population von Frankhuizen, W.S, Verschuuren, J.J.G, van Doorn, P.A, de Visser, M, Ginjaar, H.B, van der Kooi, A.J

Volltext

Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome von ANG, C. W, JACOBS, B. C, BRANDENBURG, A. H, LAMAN, J. D, VAN DER MECHE, F. G. A, OSTERHAUS, A. D. M. E, VAN DOORN, P. A

Volltext